SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-427801
Filing Date
2013-11-05
Accepted
2013-11-05 16:38:48
Documents
10
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d611955d10q.htm 10-Q 306652
2 EX-31.1 d611955dex311.htm EX-31.1 5992
3 EX-31.2 d611955dex312.htm EX-31.2 6052
4 EX-32 d611955dex32.htm EX-32 5258
  Complete submission text file 0001193125-13-427801.txt   2295137

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ck0001567514-20130930.xml EX-101.INS 243338
6 XBRL TAXONOMY EXTENSION SCHEMA ck0001567514-20130930.xsd EX-101.SCH 24105
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001567514-20130930_cal.xml EX-101.CAL 32930
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001567514-20130930_def.xml EX-101.DEF 66116
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001567514-20130930_lab.xml EX-101.LAB 222343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001567514-20130930_pre.xml EX-101.PRE 148085
Mailing Address 3960 BROADWAY NEW YORK NY 10032
Business Address 3960 BROADWAY NEW YORK NY 10032 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-54896 | Film No.: 131193108
SIC: 2834 Pharmaceutical Preparations